Investors

Event Calendar

 

Upcoming Events

Q3 2022 Financial Results week of 07 November 2022

Read more


    Year End 2022 Financial Results week of 06 March 2023

    Read more


      Past Events

      Q2 2022 Financial Results week of 15 August 2022

      August 12, 2022

      Read more

      ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference

      May 28, 2022

      Read more

      Annual General Meeting: Wednesday May 18, 2022 @ 4:30pm CET

      May 18, 2022

      Read more
      1 2 3 30

      General Meetings

      ObsEva Annual General Meeting 2022

      May 18, 2022

      Read more

      ObsEva Annual General Meeting 2021

      May 28, 2021

      Read more
      1 2 3 4
       
       

      Sign up for news

       
       

        * Type:


        InvestorHCPNursePayerHospital PharmacistRetail PharmacistOther












        Read our privacy policy here.


         

        Are you sure you want to leave ObsEva.com?

        We’re sorry to see you go. Choose one of the following actions to stay on the site or leave.

        Continue to link

        Disclaimer

        Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

        Continue

        Disclaimer

        Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

        Continue